![Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12282-020-01058-3/MediaObjects/12282_2020_1058_Fig3_HTML.png)
Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink
![The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients: data from the Korean Breast Cancer Society Registry | SpringerLink The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients: data from the Korean Breast Cancer Society Registry | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10549-019-05357-y/MediaObjects/10549_2019_5357_Fig2_HTML.png)
The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients: data from the Korean Breast Cancer Society Registry | SpringerLink
![Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome - ScienceDirect Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419344059-gr4.jpg)
Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome - ScienceDirect
![Table 4 from Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome. | Semantic Scholar Table 4 from Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1736ec52d40583bb7ee79b3f1cfc8b5cd2eb1cdc/6-Table4-1.png)
Table 4 from Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome. | Semantic Scholar
![Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients](https://www.spandidos-publications.com/article_images/ol/14/6/ol-14-06-7549-g02.jpg)
Elevation of serum CEA and CA15‑3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients
Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer | PLOS ONE
Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer | PLOS ONE
![Relationship between CA 15-3 serum levels and size of the tumor in the... | Download Scientific Diagram Relationship between CA 15-3 serum levels and size of the tumor in the... | Download Scientific Diagram](https://www.researchgate.net/publication/51364152/figure/fig1/AS:601578260164637@1520438842613/Relationship-between-CA-15-3-serum-levels-and-size-of-the-tumor-in-the-overall-population.png)
Relationship between CA 15-3 serum levels and size of the tumor in the... | Download Scientific Diagram
![Prediction of progressive disease using tumor markers in metastatic breast cancer patients without target lesions in first-line chemotherapy - Annals of Oncology Prediction of progressive disease using tumor markers in metastatic breast cancer patients without target lesions in first-line chemotherapy - Annals of Oncology](https://www.annalsofoncology.org/cms/asset/0855c376-0122-4b4e-8761-6754643d6045/gr1.jpg)
Prediction of progressive disease using tumor markers in metastatic breast cancer patients without target lesions in first-line chemotherapy - Annals of Oncology
![PDF) Recommendations for medical management of hereditary breast and ovarian cancer: The INSERM-FNCLCC ad hoc committee PDF) Recommendations for medical management of hereditary breast and ovarian cancer: The INSERM-FNCLCC ad hoc committee](https://i1.rgstatic.net/publication/13468755_Recommendations_for_medical_management_of_hereditary_breast_and_ovarian_cancer_The_INSERM-FNCLCC_ad_hoc_committee/links/00b7d519f303d6f02e000000/largepreview.png)
PDF) Recommendations for medical management of hereditary breast and ovarian cancer: The INSERM-FNCLCC ad hoc committee
![Predictive markers for pathological complete response after neo-adjuvant chemotherapy in triple-negative breast cancer - ScienceDirect Predictive markers for pathological complete response after neo-adjuvant chemotherapy in triple-negative breast cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1092913420301805-ga1.jpg)
Predictive markers for pathological complete response after neo-adjuvant chemotherapy in triple-negative breast cancer - ScienceDirect
![Axillary Lymph Node Metastasis: CA-15-3 and Carcinoembryonic Antigen Concentrations in Fine-Needle Aspirates for Preoperative Diagnosis in Patients with Breast Cancer | Radiology Axillary Lymph Node Metastasis: CA-15-3 and Carcinoembryonic Antigen Concentrations in Fine-Needle Aspirates for Preoperative Diagnosis in Patients with Breast Cancer | Radiology](https://pubs.rsna.org/cms/10.1148/radiol.09091031/asset/images/medium/09091031fig02b.jpeg)
Axillary Lymph Node Metastasis: CA-15-3 and Carcinoembryonic Antigen Concentrations in Fine-Needle Aspirates for Preoperative Diagnosis in Patients with Breast Cancer | Radiology
![Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960977620301120-gr2.jpg)
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect
![CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients | BMC Cancer | Full Text CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-14-356/MediaObjects/12885_2013_Article_4542_Fig1_HTML.jpg)
CA15-3 is a useful serum tumor marker for diagnostic integration of hybrid positron emission tomography with integrated computed tomography during follow-up of breast cancer patients | BMC Cancer | Full Text
![Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome - ScienceDirect Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419344059-gr3.jpg)
Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome - ScienceDirect
![Table 2 from Evaluation of tumor markers in southern Indian breast cancer patients. | Semantic Scholar Table 2 from Evaluation of tumor markers in southern Indian breast cancer patients. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b00ec3b5c948edf23aee4a53715047a99d635529/2-Table2-1.png)
Table 2 from Evaluation of tumor markers in southern Indian breast cancer patients. | Semantic Scholar
![Elucidating tumor heterogeneity from spatially resolved transcriptomics data by multi-view graph collaborative learning | Nature Communications Elucidating tumor heterogeneity from spatially resolved transcriptomics data by multi-view graph collaborative learning | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-33619-9/MediaObjects/41467_2022_33619_Fig1_HTML.png)
Elucidating tumor heterogeneity from spatially resolved transcriptomics data by multi-view graph collaborative learning | Nature Communications
![M1 macrophages evoke an increase in polymeric immunoglobulin receptor (PIGR) expression in MDA-MB468 breast cancer cells through secretion of interleukin-1β | Scientific Reports M1 macrophages evoke an increase in polymeric immunoglobulin receptor (PIGR) expression in MDA-MB468 breast cancer cells through secretion of interleukin-1β | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-022-20811-6/MediaObjects/41598_2022_20811_Fig1_HTML.png)